What is the treatment of hypotension in children with metabolic crisis presenting with metabolic acidosis and hyperammonemia (MAA)?

Treatment of Hypotension in Metabolic Crisis with Metabolic Acidosis and Hyperammonemia in Children

The primary approach to hypotension in children with metabolic crisis involves careful titration or reduction of arginine dosing, especially when hemodialysis is being administered concurrently, as arginine can directly cause hypotension. 1

Specific Management of Arginine-Related Hypotension

• Arginine dose titration is critical because intravenous L-arginine hydrochloride, while essential for urea cycle disorder management, can lead to hypotension as a direct adverse effect 1
• The risk is particularly elevated when arginine is given simultaneously with hemodialysis, requiring close hemodynamic monitoring and potential dose reduction 1
• Standard arginine dosing (when tolerated hemodynamically):
  • Weight <20 kg: 200 mg/kg for OTC/CPS deficiencies; 600 mg/kg for ASS/ASL deficiencies 1
  • Weight >20 kg: 4 g/m² for OTC/CPS deficiencies; 12 g/m² for ASS/ASL deficiencies 1
  • Given over 90 minutes as bolus, then maintenance over 24 hours 1

Hemodynamic Support During Dialysis

• Warming the dialysate is specifically recommended to maintain hemodynamic stability in patients receiving continuous kidney replacement therapy (CKRT) 1
• This intervention provides added hemodynamic stability, particularly important in neonates undergoing CKRT 1

General Metabolic Crisis Management to Prevent Circulatory Collapse

While not directly addressing hypotension, these measures prevent metabolic deterioration that can lead to cardiovascular instability:

• Stop all protein intake immediately to halt ammonia production 1
• Provide high-dose intravenous glucose at 8-10 mg/kg/min to reverse catabolism and prevent further metabolic decompensation 1
• Administer intravenous lipids starting at 0.5 g/kg daily, up to 3 g/kg daily 1
• Ensure adequate caloric intake ≥100 kcal/kg daily to promote anabolism 1
• Correct metabolic acidosis with bicarbonate substitution for chloride in intravenous fluids 2

Critical Pitfalls to Avoid

• Do not administer full-dose arginine without considering concurrent dialysis status - the combination significantly increases hypotension risk 1
• Do not use cold dialysate - this compromises hemodynamic stability in already vulnerable patients 1
• Do not delay arginine dose reduction if hypotension develops - the medication is likely contributing and requires immediate adjustment 1

Monitoring Parameters

• Continuous blood pressure monitoring is essential when administering arginine, particularly during the 90-minute bolus phase 1
• Reassess hemodynamic status if initiating or continuing hemodialysis in patients receiving arginine 1
• Monitor for rebound hyperammonemia after dialysis, as this may necessitate continued arginine therapy despite hypotension concerns 1